Evaxion Biotech
Evaxion: EVX-03 Gets a New Indication (Redeye)

2022-06-24 10:00
Redeye is encouraged by the news from Evaxion concerning good pre-clinical results of EVX-03 and the decision to test it in a phase I/IIa trial in lung cancer.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Evaxion Biotech ADR - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -